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Potassium permanganate (KMnO4) is an industrially significant 
manganese (Mn) compound of economic importance.[1] At room 
temperature, it exists as a fragrance-free, dark purple crystalline 
substance with a metallic sheen. It is readily water soluble, and 
aqueous solutions are pink to violet in colour, depending on the 
strength.[2] KMnO4 is a powerful oxidising agent and is commonly 
used medicinally as a topical antiseptic agent.[3,4] Nonetheless, over-
the-counter availability of KMnO4 may contribute to its potentially 
harmful properties being overlooked. For example, ingestion of 
KMnO4 may result in widespread systemic toxicity that can cause 
major morbidity and even mortality.[5] 
In South Africa (SA), KMnO4 poisoning in both adults and 
children has been reported for decades.[6-9] A recent study revealed 
46 childhood poisonings by KMnO4 at a single hospital over 
a 5-year period (2003 - 2008), eight of which included severe 
corrosive injuries.[8] Mn, in the form of KMnO4, is one of the main 
metals implicated in traditional medicine poisonings in SA.[10] The 
crystalline KMnO4 salt is easily obtainable at traditional medicine 
markets and shops throughout SA.[11] However, to date, traditional 
uses of KMnO4 have not been described; therefore, possible risks due 
to KMnO4-associated sociocultural practices remain unknown. The 
aim of this study was to document ethnopharmacological uses of 
KMnO4 in SA traditional medicine.
Methods
This sub-study on KMnO4 is part of a cross-sectional, descriptive 
study investigating metal and mineral substances used in SA 
traditional medicine, which are collectively known as imikhando in 
isiZulu; this is literally translated as ‘ore’. The results of our study on 
KMnO4, locally known as ‘double buys’ or umanyazini, are reported 
in this article. The sampling method was detailed previously.[12] In 
brief, traditional health practitioners (THPs) were recruited from 
KwaZulu-Natal, SA. A total of 201 THPs were interviewed by trained 
interviewers and a structured questionnaire was administered in 
the local language, isiZulu. Data collected via the questionnaire 
were captured on an Excel spreadsheet, then exported to Stata 
version 14 (StataCorp., USA) for analysis. For certain questions 
related to KMnO4 use, multiple responses were allowed. Reasons 
for administering KMnO4, as well as routes of administration, were 
only included if they were independently reported by ≥5 THPs. The 
participants signed an informed consent form prior to the start of 
the interview. The study was approved by the Biomedical Research 
Ethics Committee (BREC) of the University of KwaZulu-Natal (ref. 
no. BREC BF185/010).
Results
Of the 201 THPs interviewed, most were female (n=142; 71%), 
62% had practice experience of >5 years, and 30/190 (16%) had no 
(formal) schooling (Table 1). About three-quarters of the respon-
dents (n=158; 79%) reported using KMnO4 as a constituent of SA 
traditional medicine. Gender, education and years of practice were 
not significantly associated with KMnO4 use (Table 1). 
The THPs who used KMnO4 acquired the knowledge for usage 
from three different sources, i.e. fellow THPs, being self-taught or 
their ancestors (n=134, 85%; n=12, 8%; and n=11, 7%, respectively) 
(results not tabulated, 1 missing response).
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The 43 THPs provided six reasons for not administering KMnO4, 
including: (i) not knowing how to use it (n= 29; 71%); (ii) it being 
unsafe (n=6; 15%); (iii) not believing in it (n=3; 7%); (iv) according 
to their ancestors they should not use it (n=1; 2%); (v) only using 
African medicine (n=1; 2%); and (vi) only using traditional medicine 
dug from the ground, e.g. plants (n=1; 2%) (Table 2). 
Table 3 presents, in descending frequency, the 11 principal 
reasons provided by the 158 THPs for administering KMnO4. The 
main responses included use for skin rash or wounds (n=99; 63%), 
aches, pains and swelling (n=74; 47%) and gastrointestinal disorders 
(n=33; 21%). 
Eight modes of KMnO4 administration were reported, with the 
main methods being use in the bath (n=94; 60%), orally (n=67; 42%) 
and herbal compresses (n=66; 42%) (Table 4). Administration of 
KMnO4 by means of an enema was reported by 44 (28%) of THPs.
Discussion
Our study revealed a larger proportion of female than male THPs 
using KMnO4 in their healing practice (82% and 71%, respectively). 
The majority of the THPs using KMnO4 acquired the knowledge 
for usage from fellow THPs; however, with the diverse modes 
of administration and reasons for use, it was evident that the 
information relayed was not standardised and in certain cases may 
be harmful to traditional medicine users. 
Mn is recognised as an essential micronutrient, but the acute 
toxicity of KMnO4  is defined by its oxidant/irritant properties and 
by the toxicity of Mn.[13] The symptoms of KMnO4 poisoning depend 
on the route of exposure, which is most commonly ingestion.[14] 
The findings of our study revealed that 42% of the THPs administer 
KMnO4 orally. Manifestations of oral intake include nausea and 
vomiting in mild cases.[15,16] Owing to its caustic action, burns and 
ulceration of the mouth, oesophagus and stomach may occur.[5,16] 
Another common mode of KMnO4 administration is by means of an 
enema, as reported by 28% of the THPs. Caustic enemas may have 
devastating consequences.[9,17] Enemas containing caustic substances 
may be more damaging than ingestion because of the increased tissue 
contact time in the lower gastrointestinal tract.[17] Nonetheless, little is 
known about treatment and prognosis.[17] 
Two-thirds of the THPs in our study administered KMnO4 for 
healing of wounds and/or skin conditions. This is consistent with the 
customary use of KMnO4, i.e. the disinfecting and cleaning of wounds 
and as a general topical skin antiseptic.[18] Nonetheless, despite its 
long history of use, there is a lack of evidence to support KMnO4 
to aid the management of exuding wounds; therefore, its medicinal 
indication remains controversial.[19,20] It is interesting to note that 
the study by Balme et al.[8] on childhood poisoning in SA classified 
toxic substances according to the intended use of the agent and 
classified KMnO4 as an antiseptic agent. Our study provides evidence 
to consider the classification of KMnO4 under the agent category of 
traditional medicine.
Table 2. Traditional health practitioners’ reasons for not 
administering KMnO4
Reason (N=41*) n (%)
Don’t know how to use it 29 (70.7)
It is not safe to use 6 (14.6)
Don’t believe in it 3 (7.3)
Ancestors say you must not use it 1 (2.4)
Only use African traditional medicine 1 (2.4)
Only use plants 1 (2.4)
*Two responses missing.
Table 1. Demographic characteristics of study participants, stratified by KMnO4 use
Characteristics Total (N=201) KMnO4 users (n=158) Non-KMnO4 users (n=43) p-value
Gender, n (%) 0.073
Female 142 (70.6) 116 (73.4) 26 (60.5)
Male 59 (29.4) 42 (26.6) 17 (39.5)
Years of practice (in 5-year intervals), n (%)* 0.166
≤5 75 (38.1) 57 (36.8) 18 (41.9)
5.1 - 10 40 (20.3) 31 (20.7) 9 (20.9)
10.1 - 20 47 (23.9) 34 (21.9) 13 (30.2)
>20 35 (17.8) 32 (20.7) 3 (7.0)
Education, n (%)† 0.926
None 30 (15.8) 25 (17.0) 5 (11.9)
Lower primary 41 (21.6) 32 (21.6) 9 (21.4)
Higher primary 29 (15.3) 23 (15.5) 6 (14.3)
Attended high school 69 (36.3) 53 (35.8) 16 (38.1)
Completed high school 16 (8.4) 11 (7.4) 5 (11.9)
Tertiary 5 (2.6) 4 (2.7) 1 (2.4)
*Four responses missing.
†Eleven responses missing.
Table 3. Health conditions identified for treatment with 
KMnO4*
Reason (N=158) n (%)†
Skin rash or wounds 99 (62.7)
Aches, pains and swelling 74 (46.8)
Gastrointestinal: aches and cramps 33 (20.9)
Sexually transmitted diseases 23 (14.6)
Nervous conditions 23 (14.6)
Blood cleaning 14 (8.9)
Kidney and/or bladder 13 (8.2)
Aphrodisiac 7 (4.4)
Impotence 6 (3.8)
Gynaecological 5 (3.2)
HIV 5 (3.2)
*Multiple responses allowed.
†Reported by ≥5 traditional health practitioners.
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Our study revealed the use of KMnO4 for a range of sexual issues, 
including sexually transmitted infections (STIs) (23%), as an aphro-
disiac (4%), and for impotence (4%). The oral use of KMnO4 as an 
alternative treatment to prevent or cure STIs has previously been 
reported in SA.[21,22] Our study further revealed the use of KMnO4 
for HIV infection; however, the exact specification (e.g. prevention, 
management) is not given. In China, KMnO4 is reportedly used by 
female sex workers to prevent HIV and STIs,[23] despite there being 
no supporting scientific evidence.[23] 
Although general symptoms of Mn toxicity include nausea, 
vomiting and gastrointestinal tract disturbances,[5,18] there is a need 
for a comprehensive understanding of Mn risk, the mechanism 
of toxicity, clinical interventions, as well as primary prevention 
strategies.[24]
Conclusion
There is a growing body of evidence relating to Mn toxicities from a 
range of sources, which signifies its public health importance.[24] This 
study has identified traditional medicine users at risk of poisoning 
owing to sociocultural practices involving KMnO4. Healthcare 
providers may be unaware of the metal salts used in traditional 
medicine; therefore, circumstances around KMnO4 poisonings may 
be inaccurately documented and/or under-reported. To this end, 
the lack of an SA medicine pharmacopoeia is a public health threat. 
Furthermore, there is a need for poisoning prevention programmes 
that are locally relevant and culturally cognisant.
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Table 4. Traditional health practitioners’ various administration 
modes for KMnO4 use*
Administration mode (N=158) n (%)†
In bath 94 (59.9)
Oral 67 (42.4)
Herbal compress 66 (41.8)
Enema 44 (27.9)
Cutaneous implantations 25 (15.8)
Licking off finger tips 8 (5.1)
Inhalation/facial sauna 7 (4.4)
Licking off hand 6 (3.8)
*Multiple responses allowed.
† Reported by ≥5 traditional health practitioners.
